-
People who opt for nonsmoking rooms in hotels with a partial smoking ban are not fully protected from harmful exposure to so-called "thirdhand" smoke, according to a new study.More >> People who opt for nonsmoking rooms in hotels with a partial smoking ban are not fully protected from harmful exposure to so-called "thirdhand" smoke, according to a new study.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.More >> Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.More >> As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.More >> As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.More >> Eye experts warn that the adhesives used to apply eyelash extensions can cause allergies and infections.More >> Eye experts warn that the adhesives used to apply eyelash extensions can cause allergies and infections.More >>
Alabama stands to receive nearly $6 million in a national settlement with pharmaceutical giant GlaxoSmithKline, which has agreed to pay $3 billion overall to settle federal and state complaints related to marketing and pricing of its drugs.
Alabama Attorney General Luther Strange announced Monday that the state would get $5,909,500 in recoveries from the company.
GlaxoSmithKline has agreed to pay $2 billion in damages and civil penalties and a $1 billion criminal fine, settling charges it marketed certain drugs for uses not approved by the U.S. Food and Drug Administration.
Charges include marketing the depression drug Paxil for off-label use by children.
The company says it has changed compliance procedures and is pleading guilty to misdemeanor federal charges, while admitting no wrongdoing in the broader civil settlement.
READ MORE: GSK settles for $3 billion
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
All content © Copyright 2000 - 2013 WorldNow and WSFA, a Raycom Media Station.
